Overview New York, NY – Sep 04, 2025 – Global Biosimulation Market was valued at USD 3.7 Billion in 2024 and expected to grow USD 10.1 Billion in 2032. Between 2025 and 2032, this market is estimated to register a CAGR of 13.7%. Biosimulation is emerging as a critical technology in modern drug discovery and development, offering pharmaceutical […] The post Biosimulation Market to Reach USD 10.1 Billion by 2032, Growing at 13.7% CAGR appeared first on Market.us Media.
